NAT10 expression and its correlations with DNA replication factors and the clinicopathological features of prostate cancers were analyzed using prostate cancer data from the TCGA database on the UALCAN website (http://ualcan.path.uab.edu, accessed on 12 January 2022). Here, NAT10 is linked to prostate carcinoma.